Home

Pfizer (PFE)

25.77
-0.26 (-1.00%)
NYSE · Last Trade: Dec 8th, 5:45 PM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
U.S. Households Brace for Financial Headwinds Despite Steady Inflation, New York Fed Reports
New York, NY – December 8, 2025 – A recent report from the Federal Reserve Bank of New York (New York Fed) reveals a concerning trend: U.S. households are growing increasingly pessimistic about their financial situations, even as inflation expectations remain largely stable. Released today, the November 2025 Survey of Consumer
Via MarketMinute · December 8, 2025
How Do Investors Really Feel About Pfizer Inc?benzinga.com
Via Benzinga · December 8, 2025
Nasdaq, S&P 500 Futures Rise Ahead Of Fed Decision This Week: Why NFLX, CFLT, BA, LLY, IMMX Are On Traders' Radarstocktwits.com
Market-based odds now show an 87% chance of a rate cut.
Via Stocktwits · December 8, 2025
3 Cash-Producing Stocks with Exciting Potential
Free cash flow is one of the most reliable indicators of financial durability. These businesses not only generate cash but reinvest intelligently to sustain momentum.
Via StockStory · December 7, 2025
Do These 3 Healthcare Stocks Need a Checkup?fool.com
These three drugmakers are all well off their recent highs. Is this a sign of opportunity or risk?
Via The Motley Fool · December 5, 2025
Why Is Moderna (MRNA) Stock Rocketing Higher Today
Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 6.4% in the afternoon session after a major long-term study from France indicated that its COVID-19 vaccine was safe and effective. 
Via StockStory · December 5, 2025
Curious about the most active S&P500 stocks in today's session?chartmill.com
Explore the S&P500 index on Friday and find out which stocks are the most active in today's session. Stay updated with the stocks that are capturing market interest.
Via Chartmill · December 5, 2025
Is This Pharmaceutical Giant a Buy After a Major Acquisition?fool.com
The rebound is well underway.
Via The Motley Fool · December 5, 2025
2 Headwinds Facing Pfizer Stock Going Into 2026fool.com
There is plenty to be wary of with this drugmaker, but there are also reasons to be optimistic.
Via The Motley Fool · December 5, 2025
3 Low-Volatility Stocks with Warning Signs
Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.
Via StockStory · December 5, 2025
3 Reasons PFE is Risky and 1 Stock to Buy Instead
Pfizer has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 11% to $25.67 per share while the index has gained 15.3%.
Via StockStory · December 4, 2025
Trump Administration Eases Investment Deadlines For Large Pharma Companies: Reportstocktwits.com
The report added that at least one of these companies expects to fulfill the multi-billion-dollar investment pledge in full by Jan. 1, 2029.
Via Stocktwits · December 4, 2025
Global Prescription Drug Market Poised for Trillion-Dollar Surge by 2035
The global prescription drugs market is on the cusp of a significant expansion, with recent market reviews and forecasts projecting a robust growth trajectory through 2035. This anticipated surge, driven by an aging global population, the rising prevalence of chronic diseases, and relentless innovation in pharmaceutical research and development, signals
Via MarketMinute · December 3, 2025
Capricor Therapeutics (NASDAQ: CAPR) Soars 535% to Eight-Year High on Landmark Duchenne Muscular Dystrophy Treatment Results
December 3, 2025 – Capricor Therapeutics (NASDAQ: CAPR) has sent shockwaves through the biotech sector today, witnessing an astonishing 535% surge in its stock price, propelling the company to an eight-year high. The dramatic ascent follows the announcement of overwhelmingly positive top-line results from its pivotal Phase 3 HOPE-3 study for
Via MarketMinute · December 3, 2025
NSRI Launches Critical Study into Emergent Tech for Warfighter Gamma Radiation Protection
Omaha, NE – December 3, 2025 – In a pivotal move set to redefine warfighter safety in hazardous environments, the National Strategic Research Institute (NSRI) at the University of Nebraska today officially launched a comprehensive, year-long study into emergent technologies designed to protect military personnel from the devastating effects of gamma radiation. This timely initiative, [...]
Via TokenRing AI · December 3, 2025
Most active S&P500 stocks in Wednesday's sessionchartmill.com
Explore the S&P500 index on Wednesday and find out which stocks are the most active in today's session. Stay updated with the stocks that are capturing market interest and driving market movements.
Via Chartmill · December 3, 2025
Why Anthropic’s IPO Might Just Be Juicier Than OpenAI’sstocktwits.com
Both AI giants might launch their public market offerings next year.
Via Stocktwits · December 3, 2025
Most active S&P500 stocks in Tuesday's sessionchartmill.com
Curious about the most active S&P500 stocks in today's session? Join us as we explore the US markets on Tuesday and uncover the stocks that are leading the way in terms of trading volume and market attention.
Via Chartmill · December 2, 2025
2 Top Dividend Stocks to Buy Now and Hold For a Decadefool.com
These healthcare leaders can make you money while you sleep.
Via The Motley Fool · December 2, 2025
How BridgeBio, A Top 4% Stock, Is Lining Up Dominos On Its Triple-Digit Sprintinvestors.com
Shares of BridgeBio Pharma are nearing a record high as the small biotech company takes on drug behemoths Pfizer and Alnylam.
Via Investor's Business Daily · December 2, 2025
Explore the S&P500 index on Monday and find out which stocks are the most active in today's session.chartmill.com
Explore the S&P500 index on Monday and find out which stocks are the most active in today's session. Stay updated with the stocks that are capturing market interest.
Via Chartmill · December 1, 2025
Beyond the Hype: AI’s Quiet Revolution in Niche Sectors Reshapes Industries from Medicine to Agriculture
Artificial intelligence, often spotlighted for its advancements in mainstream applications like conversational agents and autonomous vehicles, is quietly orchestrating a profound transformation across an array of specialized and niche domains. Far from the public eye, AI is demonstrating unparalleled versatility, solving complex, previously intractable problems and delivering significant impact in areas ranging from accelerated drug [...]
Via TokenRing AI · December 1, 2025
Moderna, BioNTech Slammed After FDA Links Covid Shots To 10 Deathsinvestors.com
Moderna tumbled Monday after an FDA director reportedly issued a memo that says Covid shots killed 10 children.
Via Investor's Business Daily · December 1, 2025
1 Oversold Stock Primed to Rebound and 2 We Find Risky
Rock-bottom prices don't always mean rock-bottom businesses. The stocks we're examining today have all touched their 52-week lows, creating a classic investor's dilemma: bargain opportunity or value trap?
Via StockStory · December 1, 2025
S&P 500 Kicks Off December in the Red as Markets Rediscover Gravity: A Deep Dive into the Economic Headwinds
New York, NY – December 1, 2025 – The S&P 500 has begun December 2025 with a notable decline, signaling a profound shift in market sentiment as investors grapple with a confluence of challenging economic factors. This downturn, described by analysts as "rediscovering gravity," comes after a period of sustained upward
Via MarketMinute · December 1, 2025